GE HealthCare Technologies stock
Price history
+17.12% over the period1 year: from $70.63 (November 17, 2025) to $82.73 (November 17, 2026), +17.12%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $82.73 |
| October 30, 2026 | $76.57 |
| September 30, 2026 | $65.37 |
| August 31, 2026 | $71.23 |
| July 31, 2026 | $68.02 |
| June 30, 2026 | $64.01 |
| May 29, 2026 | $62.34 |
| April 30, 2026 | $60.84 |
| March 31, 2026 | $71.18 |
| February 27, 2026 | $84.27 |
| January 30, 2026 | $78.97 |
| December 31, 2025 | $82.02 |
| November 28, 2025 | $79.99 |
| November 17, 2025 | $70.63 |
At a glance
The company
Develop and market medical imaging systems, patient monitoring devices, diagnostic solutions and digital healthcare products
Latest results
Quarter to September 30, 2026 · EPS $1.36 (estimate $1.31)
TickerLandia's take on GE HealthCare Technologies
- Priced as usual relative to earnings: P/E on the latest fiscal year 18 vs a median of 18 over its last 4 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 17 vs 28 (−38%) in a group of 10.
- Strong point: Market momentum (80/100 in its group). Weak point: Dividend (9/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−8.83% from the 52-week high
Analysts · 22 analysts
Average target$87.85+7.34% vs. price
Buy 15 · Hold 7 · Sell 0 · Buy
TickerLandia Fingerprint: GE HealthCare Technologies
Compared with similar companies: very low dividend and very strong momentum.
Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricelow21
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 17.3 5 Forward P/E 14.9 18 Price/book 3.19 44 Price/sales 1.71 15 EV/EBITDA 12.6 22 Profitabilitylow37
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 13.8% 24 Gross margin 39.3% 11 ROA 5.0% 27 Net margin 10.0% 47 ROE 20.0% 76 Earnings stabilityhigh76
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.9% 95 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 56 Growthaverage47
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) +39.00% 69 Revenue growth (year over year) +7.20% 44 Average revenue growth (3 years) +3.99% 27 Financial strengthlow24
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 1.64 32 Interest coverage 8.04 32 Current ratio 1.30 18 Debt/equitycounts in reverse: lower means more financial strength 0.88 15 Dividendvery low9
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 4 years 22 Dividend yield 0.2% 2 Payout ratio 3.1% 2 Market momentumvery strong80
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +18.09% 88 Relative strength (6 months) +34.55% 90 1-year return +15.87% 56 Distance from 200-day average +16.98% 88 Riskaverage48
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 32.5% 58 Volatility (60 days) 29.8% 38 Beta (1 year) 0.64 49
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
GE HealthCare Technologies is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), GE HealthCare Technologies's P/E today is 18.2, in line with the median of its last 4 fiscal years (18.0; between 14.0 and 25.4 from 2022 to 2025). GE HealthCare Technologies's P/E (trailing 12 months): 17.3, −38% against the median of a group of 10 similar companies (28.1).
Compared with 10 similar companies
| Metric | GE HealthCare Technologies | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 17.3 | Low | |
| Forward P/E | 14.9 | Low | |
| Operating margin | 13.8% | Low | |
| ROE | 20.0% | High | |
| Debt/equity | 0.88 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: GE HealthCare Technologies. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$5.51B
Latest quarter · Q3 2026
Net income
$615M
Latest quarter · Q3 2026
Quarterly net margin
11.2%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $37B
- P/E
- 17.3
- EPS
- $4.73
- Volume
- 2.86M
- Daily trading
- €313.44M
- Dividend yield
- 0.18%
- Last ex-dividend on October 23, 2026
How GE HealthCare Technologies is changing
All resultsRevenue grew 3.7% a year on average over the last 5 years
Operating margin rose from 13.5% to 14.9%
Free cash flow equal to 87% of net income
Returns
GE HealthCare Technologies returns with dividends
$1,000 invested in GE HealthCare Technologies 3 years ago, on November 17, 2023, would be worth $1,139 today with dividends reinvested: +13.93% in total, +4.44% per year. On price alone it would be $1,133 (+13.32%).
| Period | GE HealthCare Technologies | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +18.59% | −3.17% | $1,186 |
| 6 months | +34.69% | +0.11% | $1,347 |
| Year to date | +0.86% | +8.34% | $1,009 |
| 1 year | +17.36% | +11.15% | $1,174 |
| 3 years | +13.93% | +64.30% | $1,139 |
Over the last 6 months it has done better than 72% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
GE HealthCare Technologies: technical analysis
GE HealthCare Technologies shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 12.8% below its all-time closing high ($93.87, March 8, 2024).
- Trend
- No clear trend
- RSI (14 sessions)
- 63
- Between 30 and 70
- vs 200-session average
- +16.98%
Active signals
Golden cross: the 50-session average has crossed above the 200-session average.
since November 11, 2026
Support and resistance
Price areas where GE HealthCare Technologies has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$87.34+6.72%2 touches, last on November 4, 2026
- Resistance$85.87+4.92%2 touches, last on February 4, 2026
- Last price$81.84
- Support$77.99−4.70%2 touches, last on January 29, 2026
- Support$76.09−7.03%3 touches, last on August 20, 2026
- Support$68.88−15.84%3 touches, last on March 30, 2026
Volatility and risk
Over the last year it has moved less than the S&P 500.
- Beta (1 year) vs S&P 500
- 0.64
- Volatility (60 sessions, annualised)
- 29.8%
- Largest fall in the last year
- −32.53%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
The company
GE HealthCare Technologies and its competitors
Sales outside the United States and China accounted for 45.7% of revenue in the fiscal year ended December 2025, while the United States accounted for 44.5% and China for 9.8%. The company develops, manufactures and sells equipment and digital software used to diagnose, treat and monitor patients. Its Imaging unit covers molecular imaging, CT, MR and X-ray systems, while its ultrasound and surgical visualization offerings serve areas such as cardiology and women's health.
- Headquarters
- Chicago, United States
- Employees
- 54,000
- Founded
- 1892
- Chief executive
- Peter Arduini
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| GE HealthCare TechnologiesGEHC | $37B | 13.8% | 17.3 | +34.69% |
| DexComDXCM | $30.44B | 24.0% | 32.1 | +33.12% |
| SterisSTE | $25B | 19.2% | 30.5 | +21.36% |
| Edwards LifesciencesEW | $61.59B | 28.8% | 61.6 | +29.55% |
| Boston ScientificBSX | $63.33B | 19.6% | 18.4 | −18.32% |
| Zimmer Biomet HoldingsZBH | $19.19B | 16.7% | 25.6 | +21.97% |
Same industry or related industries, similar size. Compare GE HealthCare Technologies with its competitors · Full profile
More on GE HealthCare Technologies
- GE HealthCare Technologies revenue and financials
- GE HealthCare Technologies dividend and valuation
- GE HealthCare Technologies stock return
- GE HealthCare Technologies employees, headquarters and business
